A fire at Beijing Changfeng Hospital's inpatient department claimed 21 lives, with the hospital being a listed company on the National Equities Exchange and Quotations (NEEQ), and the cause of the accident currently under investigation.
At 12:57 PM on April 18, 2023, the Fengtai District Fire Rescue Brigade received a report of a fire at the east building of Beijing Changfeng Hospital's inpatient department. Upon receiving the report, emergency responders from fire, public security, health, and emergency departments rushed to the scene. The blaze was extinguished around 1:33 PM. At 3:30 PM, the rescue operation concluded, with 71 patients evacuated.
As of 6 PM, 21 people have unfortunately died after unsuccessful medical treatment. The cause of the accident is under further investigation.
Public information reveals that Beijing Changfeng Hospital is a listed company on the National Equities Exchange and Quotations (NEEQ), with the code 870890.NQ. Corporate information shows that the legal representative of Beijing Changfeng Hospital Co., Ltd. is Wang Wenjie, established in 2009, with a current registered employee count of 311.
Located on Dianchang Road in Fengtai District, Beijing, Changfeng Hospital is a secondary comprehensive chain hospital specializing in the diagnosis and treatment of neurological disorders, vascular tumors, and vascular malformations.
The hospital focuses on the screening, diagnosis, and treatment of these diseases while also offering other comprehensive treatment options. Its subsidiaries mainly provide services in healthcare, internet technology, hospital management, and elderly care.
Founded by Wang Wenjie, one of the top ten outstanding youths of Ezhou City in Hubei Province, Beijing Changfeng Hospital Co., Ltd. is a group company specializing in hospital investment and management. It has now become a joint-stock company with investments from Yangtze Capital, CITIC Construction Investment Capital, and other investors. Since establishing its first vascular tumor specialty hospital in Ezhou City, Hubei Province, the group has gradually set up nearly 20 chain vascular tumor specialty hospitals in three municipalities and provinces with a population of over 30 million, becoming the largest vascular tumor and vascular malformation diagnostic and treatment hospital group in China.
